Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 367

The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.

Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006–2007

Open access
MacManus, Michael, Nestle, Ursula, Rosenzweig, Kenneth E., Carrio, Ignasi, Messa, Cristina, Belohlavek, Otakar, Danna, Massimo, Inoue, Tomio, Deniaud-Alexandre, Elizabeth, Schipani, Stefano, Watanabe, Naoyuki, Dondi, Maurizio, Jeremic, Branislav·2009·Radiotherapy and Oncology

Abstract

Positron Emission Tomography (PET) is a significant advance in cancer imaging with great potential for optimizing radiation therapy (RT) treatment planning and thereby improving outcomes for patients. The use of PET and PET/CT in RT planning was reviewed by an international panel. The International Atomic Energy Agency (IAEA) organized two synchronized and overlapping consultants' meetings with experts from different regions of the world in Vienna in July 2006. Nine experts and three IAEA staff evaluated the available data on the use of PET in RT planning, and considered practical methods for integrating it into routine practice. For RT planning, (18)F fluorodeoxyglucose (FDG) was the most valuable pharmaceutical. Numerous studies supported the routine use of FDG-PET for RT target volume determination in non-small cell lung cancer (NSCLC). There was also evidence for utility of PET in head and neck cancers, lymphoma and in esophageal cancers, with promising preliminary data in many other cancers. The best available approach employs integrated PET/CT images, acquired on a dual scanner in the radiotherapy treatment position after administration of tracer according to a standardized protocol, with careful optimization of images within the RT planning system and carefully considered rules for contouring tumor volumes. PET scans that are not recent or were acquired without proper patient positioning should be repeated for RT planning. PET will play an increasing valuable role in RT planning for a wide range of cancers. When requesting PET scans, physicians should be aware of their potential role in RT planning.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.radonc.2008.11.008

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 90 references

Cited by

See all 367

Metadata

Authors
MacManus, M., Nestle, U., Rosenzweig, K. E., Carrio, I., Messa, C., Belohlavek, O., Danna, M., Inoue, T., Deniaud-Alexandre, E., Schipani, S., Watanabe, N., Dondi, M., & Jeremic, B.
Venue
Radiotherapy and Oncology
Publisher
Elsevier BV
Published
2009-04
Volume
91
Issue
1
Pages
85-94
ISSN
0167-8140 (ISSN-L)
OpenAlex
W2080386114
Cited by
367
References
90
FWCI
23.65
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006–2007. https://app.cochat.ai/papers/10.1016/j.radonc.2008.11.008
The paper
MacManus, M., Nestle, U., Rosenzweig, K. E., Carrio, I., Messa, C., Belohlavek, O., Danna, M., Inoue, T., Deniaud-Alexandre, E., Schipani, S., Watanabe, N., Dondi, M., & Jeremic, B. (2009). Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006–2007. Radiotherapy and Oncology. https://doi.org/10.1016/j.radonc.2008.11.008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.